Cholesterol and Lipoprotein Metabolism Flashcards
What is the basic structure of lipoprotein?
polar surface coat (phospholipid, free cholesterol) and nonpolar lipid core (cholesterol ester, triglyceride) + apolipoproteins (embedded proteins)
Purpose of lipoprotein
transport cholesterol
Difference between triglycerides and phospholipids
phospholipids have 2 FA tails + phosphate –> polar
Lipoproteins with the largest diameter have the highest/lowest density
lowest –> will float (e.g. chylomicrons and chylomicron remants)
Which lipoprotein is it in: ApoB
chylomicrons (48), VLDL, IDL, LDL(100) AKA everything except HDL
Which lipoprotein is it in: ApoA1
HDL
Which lipoprotein is it in:ApoE
VLDL, HDL
Which lipoprotein is it in:ApoCII
chylomicrons, VLDL
Exogenous pathway for lipoprotein metabolism
fats come from intestine –> TG in chylomicrons –> lymph (aka bypass liver) –> lipoprotein lipase in tissues consumes TG –> frees FA for tissues + releases chylomicron remant (w/ApoE)–> LDLR on liver for cholesterol recylcing
What is a required cofactor for lipoprotein lipase?
ApoCII
Endogenous pathway of lipoprotein metabolism
FFA in liver adipose packaged in VLDL (B100) and released to blood –> consumed by LPL –> IDL remnant (intermediate) –> further metabolism to LDL (B100) –> LDLR
How does DM2 or insulin resistance contribute to hyperlipidemia?
increased adipose lipolysis –> higher liver production of TG –> overproduction of VLDL
Why don’t most diabetics have high ldl?
there is often a secondary breakdown in LPL that leaves everything at the VLDL stage
Etiology: Familial chylomicronemia syndrome
mutations in LPL or ApoCII lead to reduced breakdown of chylomicrons and result in chylomicronemia
Presentation of FCS
eruptive xanthomas, pancreatitis
Etiology: Familial dysbetalipoproteinemia
After breakdown of chylomicron, chylomicron remant takes on ApoE which provides docking with the liver (also involved in VLDL remant/IDL uptake)
–> if you have homozyogous ApoE2 instead of 3 or 4, you get buildup of remants of chylomicrons and VLDL
Presentation of FD
xnathomata over elbows, palmar xanthomas, CHD
Etiology: Familial hypercholesterolemia
mutations in LDLR prevent docking of LDL and disrupts cholesterol metabolism –> LDL buildup
can be heterozyogous or homozygous (worse)
Presentation of FH
corneal arcus, xanthelasma, tendon xanthoma (very specific for FH), CHD, normal TG
*significant cutaneous xanthomas in homozyogous FH
What’s the difference between FH and FDB
familial defective apoB-100 involves mutation in apoB in the docking strip for LDLR –> same presentation but different mutation
Etiology: Autosomal dominant hypercholesterolemia 3 (ADH3)
increased pcsk9 negatively regulates LDL receptor
Gain of function or loss of function in Pcsk9 cause severe hypercholesterolemia
gain of function
Etiology: Familial hypertriglyceridemia
VLDL metabolism breaks down
Clinical presentation of FHTG
high VLDL and triglycerides –> if type 5 (severe) severe eruptive xanthomas, pancreatitis, CHD